newsfilter
← Latest News
PR Newswire·

Scinai Announces Annual Financial Results for 2024

Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) ("Scinai", or the "Company"), a biopharmaceutical company focused on developing novel and innovative...